111 Inc
NASDAQ:YI
111 Inc
Cash from Financing Activities
111 Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
111 Inc
NASDAQ:YI
|
Cash from Financing Activities
¥206m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
Cash from Financing Activities
-¥1.8B
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-75%
|
CAGR 10-Years
N/A
|
LBX Pharmacy Chain JSC
SSE:603883
|
Cash from Financing Activities
-¥1.9B
|
CAGR 3-Years
-112%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yunnan Jianzhijia Health-Chain Co Ltd
SSE:605266
|
Cash from Financing Activities
¥1.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
Cash from Financing Activities
-¥2.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
|
Cash from Financing Activities
-¥1.3B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is 111 Inc's Cash from Financing Activities?
Cash from Financing Activities
206m
CNY
Based on the financial report for Dec 31, 2023, 111 Inc's Cash from Financing Activities amounts to 206m CNY.
What is 111 Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-27%
Over the last year, the Cash from Financing Activities growth was 806%. The average annual Cash from Financing Activities growth rates for 111 Inc have been -42% over the past three years , -27% over the past five years .